Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online December 13, 2016.
Article Versions
- previous version (September 4, 2016 - 12:45).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2016
Author Information
- Arifa S. Khan1,*,
- Dominick A. Vacante2,
- Jean-Pol Cassart3,
- Siemon H. S. Ng4,
- Christophe Lambert5,
- Robert L. Charlebois4 and
- Kathryn E. King6
- 1Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD;
- 2Janssen Research & Development, LLC, Malvern, PA;
- 3GlaxoSmithKline Vaccines, Wavre, Belgium;
- 4Analytical Research and Development, Sanofi Pasteur. Toronto, ON, Canada;
- 5GlaxoSmithKline Vaccines, Rixensart, Belgium; and
- 6Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
- ↵* Corresponding Author: Dr. Arifa S. Khan, Laboratory of Retroviruses, Division of Viral Products, Office of Vaccines Research and Review, CBER/FDA, 10903 New Hampshire Ave, HFM-454, Bldg 52-72, Room 1216, Silver Spring, MD 20993 USA; e-mail: arifa.khan{at}fda.hhs.gov. Dr. Dominick Vacante, Janssen Research & Development, LLC, 200 Great Valley Parkway, Malvern, PA 19355; e-mail: dvacante{at}its.jnj.com.
Cited By...
Jump to section
Related Articles
Cited By...
- Proceedings of the 2023 Viral Clearance Symposium, Session 8: Cell Banks, Advanced Technologies (ATMPs, NGS)
- A Reference Viral Database (RVDB) To Enhance Bioinformatics Analysis of High-Throughput Sequencing for Novel Virus Detection
- A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection